United States · FDA National Drug Code directory
GLATIRAMER ACETATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70710-1548_fe3feaf2-7856-4040-a0fe-4c7be5f3ebba
- Product NDC
- 70710-1548
- Form
- INJECTION, SOLUTION
- Composition / generic term
- glatiramer acetate
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251110
- Source listing expiry
- 20271231
Source-listed ingredients
- GLATIRAMER ACETATE — 20 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 BLISTER PACK in 1 CARTON (70710-1548-9) / 1 SYRINGE in 1 BLISTER PACK / 1 mL in 1 SYRINGE (70710-1548-2) · 70710-1548-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →